ASTRAZENECA PLC (AZN)
Clinical trial NCT02519348: completion date: 2026-04-01 → 2026-12-18.
Clinical trial NCT02519348: completion date: 2026-04-01 → 2026-12-18.
Clinical trial NCT05703971: primary completion date: 2026-02-01 → 2026-06-01.
Dormant shares - change in the number of shares
Globaltech Corp. (OTCQB: GLTK) Update to Shareholders
FORM 4-Tepper Oren
The Road to WorldSkills - DEWALT® Backs Two American Competitors Representing the USA at the Worlds Premier Skilled Trades Competition
FORM 10-Q For third quarter ended April 30, 2026.
Experienced Advisory Team With $160 Million in Assets Joins Ameriprise Financial for Enhanced Client Experience and Advanced Capabilities
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
Nasdaq Resumes Trading in TJGC Group Limited